Search Atlas Launches White-Label SEO Platform with Autonomous OTTO AI Engine for Agencies
Search Atlas releases a full-suite SEO platform with OTTO AI, enabling agencies to deliver services under their own brand without manual intervention, consolidating multiple tools into one system.
Twin Vee PowerCats Reports Q1 2026 Revenue Growth, Continues Bahama Brand Expansion
Twin Vee PowerCats Co. announced a 10% year-over-year revenue increase in the first quarter of 2026, its fourth consecutive quarter of growth, while advancing the relaunch of its Bahama Boat Works lux...
Datavault AI Positions Edge Computing Network for Anticipated Digital Asset Regulation
Datavault AI highlights its distributed edge computing strategy ahead of U.S. Senate markup of the Digital Asset Market Clarity Act, expecting regulatory clarity to boost demand for secure data proces...
Ev0-Tech Founder Dan Vega Responds to CDM Report Highlighting SMBs as Fastest-Growing Cyberattack Target
Cyber Defense Magazine's May 2026 report names small businesses as the fastest-growing attack surface, prompting Ev0-Tech founder Dan Vega to reaffirm his firm's 'Security First' model for SMBs.
Search Atlas Launches Atlas Agent with Domain Power and LLM Visibility Metrics
Search Atlas introduces Atlas Agent, an autonomous conversational AI for end-to-end digital marketing, alongside new metrics Domain Power and LLM Visibility to measure brand presence in AI-generated a...
Keona Health Publishes Nursing Triage ROI Guidance Highlighting Hidden Costs of Manual Processes
Keona Health released ROI guidance and a calculator to help healthcare organizations quantify the financial and operational impact of manual triage versus AI-assisted workflows, revealing potential sa...
Survey Finds 53% of Standing Workers Experience Frequent Foot Pain, Yet Orthotic Use Remains Low
A new Footminders survey reveals that over half of workers who stand for long hours suffer from frequent foot pain, but only 22% use orthotic insoles, highlighting a gap in workplace wellness.
SureNano Science Initiates IND-Enabling Program for Obesity and Diabetes Drug GEP-44
SureNano Science has begun a GLP toxicology and pharmacology program for its lead candidate GEP-44, aiming to enter the $200 billion GLP-1 market with a multi-receptor peptide targeting obesity and ty...
Atlanta Clinic Expands Regenerative and Hair Restoration Services Under One Roof
Springs Rejuvenation's Atlanta clinic now offers stem cell exosome therapy, advanced FUE hair restoration, and regenerative joint protocols, providing minimally invasive alternatives to traditional tr...
Wisconsin’s First Emergency Mental Health Facility Opens in La Crosse
Emplify Health by Gundersen has opened Wisconsin’s first dedicated emergency mental health facility, the EmPATH unit, to provide specialized care for individuals in crisis and reduce ER wait times.
Choosing the Right Oral Rinse: Experts Say Personalization Is Key to Oral and Overall Health
Oral care experts at ioTech International advise consumers to select oral rinses based on specific health needs rather than brand or flavor, highlighting the importance of therapeutic benefits and the...
MindBio Therapeutics Expands AI Voice Diagnostics Platform with Fatigue Detection Technology for High-Risk Industries
MindBio Therapeutics Corp. announced the development of AI-powered fatigue recognition technology that analyzes voice patterns, to be added as a commercial feature to its Edge AI Intoxication Detectio...
HeartBeam Launches Pilot Study for On-Demand 12-Lead ECG Patch in Coronary Artery Disease Patients
HeartBeam initiated a pilot study for its investigational patch-based 12-lead ECG device aimed at detecting ischemia, targeting a $2 billion market and expanding ambulatory cardiac monitoring beyond r...
Oncotelic Therapeutics Leverages Partnership Model to Advance Pipeline Without Dilution
Oncotelic Therapeutics is using a partnership-driven strategy, including a GMP Bio joint venture that added $249 million to its balance sheet, to advance its drug pipeline and AI platform without dilu...
SPARC AI Targets Defense Autonomy Software Opportunity as Drone Warfare Accelerates
SPARC AI Inc. is developing a software-only system for GPS-denied navigation and precision targeting in drones, addressing a critical gap as defense agencies prioritize scalable autonomous systems.
SureNano Science Advances GEP-44 Triple Agonist as Obesity Drug Market Poised to Exceed $200 Billion
SureNano Science Ltd., through GlucaPharm Inc., is progressing its patented triple agonist peptide GEP-44 for obesity and metabolic diseases, aiming to compete in a market projected to exceed $200 bil...
SureNano Science Advances Next-Generation GLP-1 Platform with Triple Agonist GEP-44 Amid Growing Obesity and Diabetes Crisis
SureNano Science Ltd., through its subsidiary GlucaPharm Inc., is developing GEP-44, a novel triple agonist peptide for GLP-1 therapy, aiming to improve efficacy, tolerability, and delivery flexibilit...
Apple to Pay $250M Settlement Over iPhone AI Marketing Claims
Apple has agreed to a $250 million settlement in a U.S. lawsuit alleging it misled customers about the capabilities and availability of its Apple Intelligence AI features for iPhones.
Earlier Immunotherapy Timing May Improve Survival in Late-Stage Cancers, Study Finds
A systematic review in JAMA Network Open suggests that earlier administration of immune checkpoint inhibitors may improve survival outcomes in patients with late-stage solid tumors, with implications ...
Geopolitical Risks Drive Volatility in Copper Market, ING Analysis Shows
The copper market is experiencing heightened volatility driven by geopolitical uncertainties rather than traditional supply-demand fundamentals, according to an ING analysis, with implications for min...
Voice Analysis AI Could Revolutionize Intoxication Detection, MindBio Therapeutics Leads the Way
MindBio Therapeutics is developing an AI-driven voice analysis platform to detect drug and alcohol intoxication from short speech samples, offering a noninvasive, real-time alternative to traditional ...
CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities
Innovations in crossing the blood-brain barrier, such as Oncotelic's intranasal nose-to-brain system, are poised to transform treatment for neurological diseases and open new biotech market opportunit...
MindBio Therapeutics Develops AI Voice Analysis Platform for Real-Time Intoxication Detection
MindBio Therapeutics is advancing an AI-driven voice analysis platform to detect drug and alcohol intoxication in real time, targeting growing markets in workplace safety, healthcare, and public safet...
Software, Not Hardware, Drives the Next Phase of Drone Warfare
As cheap drones flood battlefields, their reliance on GPS and human control creates vulnerabilities, pushing defense leaders toward software-based autonomy solutions like SPARC AI's GPS-denied navigat...
PAT Express Logistics Marks 20 Years of Australian Freight Forwarding and 3PL Services
PAT Express Pty Ltd celebrates two decades of operation as an Australian-owned logistics provider, expanding from freight forwarding to full-service 3PL, project logistics, and commercial furniture in...
Oncotelic Therapeutics Targets CNS Drug Delivery Opportunity with Intranasal Platform as Brain Therapeutics Innovation Accelerates
Oncotelic Therapeutics is advancing its intranasal nose-to-brain delivery platform to address the challenge of delivering therapeutics across the blood-brain barrier, targeting Alzheimer's disease and...
Planet Ventures Targets Orbital Power Infrastructure as Energy Becomes Space Economy's New Bottleneck
Planet Ventures Inc. is positioning itself in the emerging orbital power race, recognizing that scalable energy infrastructure in space is becoming a critical constraint as satellite networks and AI w...
NanoViricides Highlights Broad-Spectrum Antiviral Candidate After Andes Hantavirus Incident on Cruise Ship
Following an Andes hantavirus incident aboard a cruise ship, NanoViricides underscores the potential need for broad-spectrum antiviral treatments, pointing to its clinical-stage drug candidate NV-387 ...